no-spa süstelahus
opella healthcare france s.a.s. - drotaveriin - süstelahus - 20mg 1ml 2ml 25tk; 20mg 1ml 2ml 5tk
no-spa tablett
opella healthcare france s.a.s. - drotaveriin - tablett - 40mg 20tk; 40mg 24tk
no-spa tablett
first pharma oÜ - drotaveriin - tablett - 40mg 24tk; 40mg 20tk
no-spa õhukese polümeerikattega tablett
opella healthcare france s.a.s. - drotaveriin - õhukese polümeerikattega tablett - 40mg 24tk
delstrigo
merck sharp & dohme b.v. - doravirine, lamivudine, tenofovir disoproxil dietüülfumaraat - hiv-nakkused - viirusevastased ravimid hiv-infektsioonide raviks, kombinatsioonid - delstrigo on näidustatud ravi täiskasvanud nakatunud hiv-1, ilma et varem või esitab tõendid takistuse nnrti klassi, lamivudine, või tenofovir. delstrigo is also indicated for the treatment of adolescents aged 12 years and older weighing at least 35 kg who are infected with hiv-1 without past or present evidence of resistance to the nnrti class, lamivudine, or tenofovir and who have experienced toxicities which preclude the use of other regimens that do not contain tenofovir disoproxil.
pifeltro
merck sharp & dohme b.v. - doravirine - hiv-nakkused - viirusevastased ravimid süsteemseks kasutamiseks - pifeltro is indicated, in combination with other antiretroviral medicinal products, for the treatment of adults, and adolescents aged 12 years and older weighing at least 35 kg infected with hiv 1 without past or present evidence of resistance to the nnrti class.